Anika Therapeutics Inc (ANIK)

R&D Expense Growth

9.35%

Quarterly · Period ending:

ANIK logo

ANIK R&D Expense Growth

Latest reported9.35%
ANIK Quarterly R&D Growth (QoQ) (0.00% → 9.35%)
High-resolution chart · PNG

ANIK r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Anika Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
-31.6459%
157.7939%
1.2936%
-43.1045%
-30.9431%
-6.1616%
16.6667%
33.3333%
28.5714%
16.6667%
20%
25%
-20%
0%
-16.6667%
20%
66.6667%
-50%
20%
0%
25%
33.3333%
-25%
33.3333%
0%
-25%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.